225 related articles for article (PubMed ID: 18573134)
1. Diet, inflammation, and chronic kidney disease: getting to the heart of the matter.
Neade T; Uribarri J
Semin Dial; 2008; 21(4):331-7. PubMed ID: 18573134
[TBL] [Abstract][Full Text] [Related]
2. Vascular disease and chronic renal failure: new insights.
Nanayakkara PW; Gaillard CA
Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816
[TBL] [Abstract][Full Text] [Related]
3. Protecting the endothelium: a new focus for management of chronic kidney disease.
Diaz-Buxo JA; Woods HF
Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
[TBL] [Abstract][Full Text] [Related]
4. Contribution of inflammation to vascular disease in chronic kidney disease patients.
Suliman ME; Stenvinkel P
Saudi J Kidney Dis Transpl; 2008 May; 19(3):329-45. PubMed ID: 18445891
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
[TBL] [Abstract][Full Text] [Related]
6. Implications of chronic kidney disease for dietary treatment in cardiovascular disease.
Packard DP; Milton JE; Shuler LA; Short RA; Tuttle KR
J Ren Nutr; 2006 Jul; 16(3):259-68. PubMed ID: 16825032
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
Tain YL
Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
[TBL] [Abstract][Full Text] [Related]
9. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A;
Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease and cardiovascular disease: a case presentation.
McCarley PB; Salai PB
Nephrol Nurs J; 2007; 34(2):187-98; quiz 199-200. PubMed ID: 17486949
[TBL] [Abstract][Full Text] [Related]
11. Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease.
McCullough PA; Lepor NE
Rev Cardiovasc Med; 2005; 6 Suppl 3():S4-12. PubMed ID: 16340933
[TBL] [Abstract][Full Text] [Related]
12. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
Kundhal K; Lok CE
Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
[TBL] [Abstract][Full Text] [Related]
13. [Vascular risk factors and renal failure].
Madore F
Med Sci (Paris); 2004 Dec; 20(12):1100-3. PubMed ID: 15581463
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?
Kalantar-Zadeh K
Semin Dial; 2005; 18(5):365-9. PubMed ID: 16191172
[TBL] [Abstract][Full Text] [Related]
15. The renal patient with cardiovascular disease--no longer a simple plumbing problem.
Tunuguntla A; Yerra L
Tenn Med; 2005 Aug; 98(8):395-6, 399. PubMed ID: 16315466
[TBL] [Abstract][Full Text] [Related]
16. hsCRP, sICAM-1 and TAFI in hemodialysis patients: linking inflammation and hypofibrinolysis to cardiovascular events.
Gad MZ; El-Mesallamy HO; Sanad EF
Kidney Blood Press Res; 2008; 31(6):391-7. PubMed ID: 19052466
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
Roberts MA; Hare DL; Ratnaike S; Ierino FL
Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
[TBL] [Abstract][Full Text] [Related]
18. New insights on inflammation in chronic kidney disease-genetic and non-genetic factors.
Stenvinkel P
Nephrol Ther; 2006 Jul; 2(3):111-9. PubMed ID: 16890135
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
Maruyama Y; Lindholm B; Stenvinkel P
J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction and chronic kidney disease: treatment options.
Wu-Wong JR
Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
